Noida-based Marion Biotech’s License Suspended Over Uzbekistan Child Deaths
Noida-based pharmaceutical firm Marion Biotech which has been linked with the death of 18 children in Uzbekistan has lost its production license. The suspension was officially issued to the company which it accepted. The company has been accused of manufacturing a substandard cough syrup that was linked with the death of those children.
In December last year, Noida-based pharmaceutical firm Marion Biotech which manufactures cough syrup Ambronol and Dok-1 Max was accused of causing the death of 18 children in Uzbekistan after they were given these cough syrups. Neither of the two cough syrups are sold in India and are only exported to Uzbekistan. On December 22, 2022, the World Health Organization (WHO) identified two substandard (contaminated) products and issued a ‘medical product alert.’
On December 29, an inspection of the Noida facility was carried out and six samples of Dok-1 Max were taken for testing. At the time, the company was asked for production documents related to the cough syrup but the staff could not produce them. The government then shut down production of the cough syrup. The suspension of the production license was ordered the same day. On January 10, the written suspension was issued to the company which it accepted, according to Gautam Buddh Nagar Drug Inspector Vaibhav Babbar.
Similar stories
Comments are closed.